English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

ss Open Acce Meeting abstract A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer Claudia Arce2, Carlos Perez-Plasencia1, Aurora Gonzalez-Fierro1, Erik de la Cruz-Hernandez1, Alma Revilla-Vazquez3, Alma Chavez-Blanco1, Catalina Trejo-Becerril1, Enrique Perez-Cardenas1, Lucia Taja-Chayeb1, Enrique Bargallo4, Patricia Villarreal4, Teresa Ramirez4, Teresa Vela5, Myrna Candelaria2, Maria F Camargo1, Elizabeth Robles2 and Alfonso Duenas-Gonzalez*1

bmc cancer

A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer